Literature DB >> 9783649

Intermittent claudication and risk of cardiovascular events.

G Brevetti1, V D Martone, S Perna, F Cacciatore, S Corrado, A Di Donato, A Di Iorio.   

Abstract

To determine the natural history of intermittent claudication, 110 patients were followed up for a mean period of 24.4 +/- 1.2 months. Four patients died during the follow-up. Of the survivors, 24 experienced a nonfatal cardiovascular event, myocardial infarction being the most frequent. Cumulative cardiovascular morbidity was 29% at 3 years. Cox proportional-hazards analysis showed initial ankle-brachial pressure index (ABPI) as a significant predictor for nonfatal cardiovascular events (p<0.002). With an initial ABPI >0.70, cardiovascular morbidity rate was 12% compared with 33% for those with initial ABPI ranging from 0.70 to 0.50, and 60% for those with ABPI <0.50 (p<0.005). Critical limb ischemia occurred in only four patients, amputation was required in two, and arterial reconstruction in five. Of the 85 patients who participated in the treadmill test, maximum walking capacity worsened in 26% and improved in 27%. This study elucidates the neglected area of cardiovascular morbidity in intermittent claudication. It has shown that ABPI identifies a subgroup of patients for whom the risk of cardiovascular events is especially pronounced. On the other hand, based on objective evaluation of the patient status, the relatively benign prognosis for the claudicant limb has been confirmed.

Entities:  

Mesh:

Year:  1998        PMID: 9783649     DOI: 10.1177/000331979804900908

Source DB:  PubMed          Journal:  Angiology        ISSN: 0003-3197            Impact factor:   3.619


  4 in total

Review 1.  Peripheral artery disease: epidemiology and global perspectives.

Authors:  F Gerry R Fowkes; Victor Aboyans; Freya J I Fowkes; Mary M McDermott; Uchechukwu K A Sampson; Michael H Criqui
Journal:  Nat Rev Cardiol       Date:  2016-11-17       Impact factor: 32.419

2.  Intermittent claudication: pharmacoeconomic and quality-of-life aspects of treatment.

Authors:  Gregorio Brevetti; Roberta Annecchini; Roxanna Bucur
Journal:  Pharmacoeconomics       Date:  2002       Impact factor: 4.981

3.  Decrease in circulating dendritic cell precursors in patients with peripheral artery disease.

Authors:  Daniel Kretzschmar; Ilonka Rohm; Sebastian Schäller; Stefan Betge; Rudin Pistulli; Yevgeniya Atiskova; Hans-R Figulla; Atilla Yilmaz
Journal:  Mediators Inflamm       Date:  2015-04-15       Impact factor: 4.711

4.  Physical Activity Levels in Peripheral Artery Disease Patients.

Authors:  Aline Mendes Gerage; Marilia de Almeida Correia; Paulo Mesquita Longano de Oliveira; Aline Cabral Palmeira; Wagner Jorge Ribeiro Domingues; Antônio Eduardo Zeratti; Pedro Puech-Leão; Nelson Wolosker; Raphael Mendes Ritti-Dias; Gabriel Grizzo Cucato
Journal:  Arq Bras Cardiol       Date:  2019-07-29       Impact factor: 2.000

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.